61.
Efficacy and safety of ezetimibe added to ongoing statin therapy for treatment of patients with primary hypercholesterolemia
by Gagné, Claude
The American journal of cardiology, 2002, Vol.90 (10), p.1084-1091
62.
An update on the IMProved Reduction of Outcomes: Vytorin Efficacy International Trial (IMPROVE-IT) design
by Califf, Robert M., MD
The American heart journal, 2010, Vol.159 (5), p.705-709
63.
Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease
by Marazzi, Giuseppe, MD, PhD
The American journal of cardiology, 2015, Vol.116 (12), p.1798-1801
64.
Critical Appraisal of the SHARP Trial: The Results May Be Dull
by Harbin, Megan, BScPharm, ACPR
Clinical therapeutics, 2014, Vol.36 (12), p.2112-2117
65.
Velocity ratio predicts outcomes in patients with low gradient severe aortic stenosis and preserved EF
by Jander, Nikolaus
Heart (British Cardiac Society), 2014, Vol.100 (24), p.1946-1953
66.
Ezetimibe-Simvastatin Therapy Reduce Recurrent Ischemic Stroke Risks in Type 2 Diabetic Patients
by Liu, Chi-Hung
The journal of clinical endocrinology and metabolism, 2016, Vol.101 (8), p.2994-3001
67.
Comparison of Pharmacokinetics and Safety of a Fixed-dose Combination of Rosuvastatin and Ezetimibe Versus Separate Tablets in Healthy Subjects
by Min, Kyoung Lok
Clinical therapeutics, 2017, Vol.39 (9), p.1799-1810
68.
Impact of Switching From High-Efficacy Lipid-Lowering Therapies to Generic Simvastatin on LDL-C Levels and LDL-C Goal Attainment Among High-Risk Primary and Secondary Prevention Po...
by Cao, Xiting, PhD
Clinical therapeutics, 2015, Vol.37 (4), p.804-815
69.
Indices of Cholesterol Metabolism and Relative Responsiveness to Ezetimibe and Simvastatin
by Lakoski, Susan G
The journal of clinical endocrinology and metabolism, 2010, Vol.95 (2), p.800-809
70.
Statins, Ezetimibe, and Proprotein Convertase Subtilisin–kexin Type 9 (PCSK9) inhibitors to Reduce Low-Density Lipoprotein-Cholesterol and Cardiovascular Events
by O’Keefe, James H., MD
The American journal of cardiology, 2016, Vol.119 (4), p.565-571
71.
The effect of simvastatin alone versus simvastatin plus ezetimibe on the concentration of small dense low-density lipoprotein cholesterol in subjects with primary hypercholesterole...
by Florentin, Matilda
Current medical research and opinion, 2011, Vol.27 (3), p.685-692
72.
Efficacy and Safety of Rosuvastatin 40 mg Alone or in Combination With Ezetimibe in Patients at High Risk of Cardiovascular Disease (Results from the EXPLORER Study)
by Ballantyne, Christie M., MD
The American journal of cardiology, 2007, Vol.99 (5), p.673-680
73.
Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with hypercholesterolaemia: systematic review and meta-analysis
by Mikhailidis, Dimitri P
Current medical research and opinion, 2011, Vol.27 (6), p.1191-1210
74.
Lipid-modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-density Lipoprotein Cholesterol
by Ballantyne, Christie M., MD
The American journal of cardiology, 2016, Vol.119 (3), p.388-396
75.
The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low...
by Anon
The American heart journal, 2011, Vol.161 (3), p.471-477
76.
Inhibitors of Hepatitis B Virus Attachment and Entry
by Lempp, Florian A
Intervirology, 2014, Vol.57 (3-4), p.151-157
77.
Meta-analysis of the cholesterol-lowering effect of ezetimibe added to ongoing statin therapy
by Mikhailidis, D. P
Current medical research and opinion, 2007, Vol.23 (8), p.2009-2026
78.
Impact on Optical Coherence Tomographic Coronary Findings of Fluvastatin Alone Versus Fluvastatin + Ezetimibe
by Habara, Maoto, MD
The American journal of cardiology, 2014, Vol.113 (4), p.580-587
79.
Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: The Vytorin Versus Atorvastatin (VYVA) St...
by Ballantyne, Christie M
The American heart journal, 2005, Vol.149 (3), p.464-473
80.
Efficacy and safety of a potent new selective cholesterol absorption inhibitor, ezetimibe, in patients with primary hypercholesterolemia
by Dujovne, Carlos A
The American journal of cardiology, 2002, Vol.90 (10), p.1092-1097
